Resistance to methicillin and virulence of Staphylococcus aureus strains in bacteriemic cancer patients

Intensive Care Med. 1993;19(5):285-9. doi: 10.1007/BF01690549.

Abstract

Objective: To estimate the relation between resistance to methicillin and virulence in strains of Staph. aureus by estimating the survival at day 30.

Design: Case control analysis.

Setting: Inpatients at a major Cancer Referral Center.

Patients: 21 patients with methicillin-resistant Staph. aureus (MRSA) bactaeremia and 45 patients with methicillin-susceptible Staph. aureus (MSSA) bactaeremia, all treated with vancomycin.

Measurements and main results: Fewer MRSA than MSSA patients were neutropenic (p = 0.04), but more MRSA patients were hospitalized in intensive care units (p = 0.03), had had surgical episodes (p = 0.06). MRSA patients also had more microbiological samples cultured (p = 0.007). The outcome of the bacteriemic episodes in 14 MRSA and 14 MSSA patients matched for these four factors showed that blood cultures from MRSA patients remained positive significantly longer (p = 0.04), but that survival and length of hospital stay were not significantly different.

Conclusions: These results do not indicate that methicillin-resistance in Staph. aureus is associated with increased virulence.

Publication types

  • Comparative Study

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Bacteremia / blood
  • Bacteremia / complications
  • Bacteremia / epidemiology
  • Bacteremia / microbiology*
  • Bacteremia / therapy
  • Cancer Care Facilities
  • Case-Control Studies
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Intensive Care Units
  • Length of Stay / statistics & numerical data
  • Male
  • Matched-Pair Analysis
  • Methicillin Resistance*
  • Middle Aged
  • Neoplasms / complications*
  • Neutropenia / complications
  • Prognosis
  • Referral and Consultation
  • Staphylococcal Infections / blood
  • Staphylococcal Infections / complications
  • Staphylococcal Infections / epidemiology
  • Staphylococcal Infections / microbiology*
  • Staphylococcal Infections / therapy
  • Staphylococcus aureus / pathogenicity*
  • Survival Analysis
  • Survival Rate
  • Vancomycin / blood
  • Vancomycin / therapeutic use

Substances

  • Vancomycin